儿童从急性胰腺炎发展为慢性胰腺炎:系统性审查和元分析
Endre Botond Gagyi1,2,3, Mahmoud Obeidat1, Edina Tari1,4
1Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
Clinical and experimental pediatrics
|December 11, 2025
概括
大约18%的儿童在初始发作后出现复发性急性胰腺炎 (RAP),其中35%的儿童发展为慢性胰腺炎 (CP). 病因,严重程度,结构和遗传因素影响这些儿科胰腺炎进展风险.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 胰腺学 胰腺学
- 临床流行病学临床流行病学
背景情况:
- 儿童的急性胰腺炎 (AP) 可以导致复发性胰腺炎 (RAP) 或慢性胰腺炎 (CP).
- 了解进展率和风险因素对于儿科AP管理至关重要.
研究的目的:
- 在儿科群体中量化从初始AP到RAP和CP的进展率.
- 确定与AP进展相关的临床,结构和遗传风险因素.
主要方法:
- 来自PubMed/MEDLINE,Embase和Cochrane数据库的观察性研究的系统审查和元分析.
- 包括的研究报告了儿科患者的RAP或CP进展.
- 使用随机效应模型组合比例和赔率比率 (ORs);用I2统计数据评估异质性.
主要成果:
- 18%的儿童在第一个AP插曲后发展为RAP;10%的儿童发展为CP.
- 在患有RAP的儿童中,有35%的儿童发展为CP.
- 随着病因 (例如,高甘油三血症33%) 和严重程度 (严重39%) 的不同,RAP的发病率有所不同.
- 结构异常 (OR 3.15),胰腺分裂 (OR 2.64) 和PRSS1突变 (OR 4.56) 与发展为RAP/CP.相关.
结论:
- 儿科AP复发是显著的,其中很大一部分进展为慢性疾病.
- 最初的AP事件特征 (病因,严重程度) 影响RAP风险.
- 结构性和遗传因素是长期进展到CP的关键预测因素.
相关概念视频
Chronic Pancreatitis I: Introduction
645
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
645
Chronic Pancreatitis II: Collaborative Care
286
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
286
Acute Pancreatitis I: Introduction
1.1K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.1K
Acute Pancreatitis II: Clinical Manifestations and Management
702
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
702
Pharmacokinetics in Pediatric Patients: Drug Metabolism
174
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
174
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229


